Skip to content
Sunday, November 15, 2026
Diamond Signal

Zimbabwe Declines ‘One-Sided’ American Healthcare Assistance Deal Due to Information Apprehensions

Health aid illustration
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to the United States' insistence on confidential data.

This move was revealed after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".

A government spokesman has since stated that the US was requesting biological samples for scientific study and commercial purposes while was unwilling to share the benefits from any future vaccines.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for more talks to reach a agreement agreeable to both sides so the nation's vital HIV treatment initiative can continue.

Wider Context

This rejection comes after a similar case in neighbouring Kenya, where a court suspended a related deal with the US after concerns were filed about the security of Kenyans' medical information.

Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.

As per statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Deal

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research without any assurance that the end products would be available to our citizens if a future health crisis arise."

National Interest and Global Health

Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously established through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.

"This framework is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.

"We are open to ongoing dialogue with our US partners on how future co-operation might be arranged in a manner that honours the independence and dignity of each country."

Health Experts Reaction

Medical experts stated it understood the official position, but urged that talks should continue given that much of the nation's HIV programmes relied on international support.

"If specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.

The halted deal underscores the continuing challenges between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.

About the author

Kevin Carroll

Lena is a financial analyst specializing in blockchain technology and cryptocurrency markets, with over 8 years of trading experience.

Diamond Signal

Type to search articles.